Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus
Amrita K Cheema,1 Prabhjit Kaur,1 Amina Fadel,2 Noura Younes,3 Mahmoud Zirie,4 Nasser M Rizk2,5 1Department of Oncology, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC, USA; 2Biomedical Sciences Department, College of Health Sciences and Biomedical Resea...
Guardado en:
Autores principales: | Cheema AK, Kaur P, Fadel A, Younes N, Zirie M, Rizk NM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/113f03c14d3041c29cee9687f2d39e47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
por: Tafere GG, et al.
Publicado: (2020) -
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
por: Badawi A
Publicado: (2010) -
Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
por: Lingxiao Wang, et al.
Publicado: (2021) -
Novel biomarkers for prediabetes, diabetes, and associated complications
por: Dorcely B, et al.
Publicado: (2017) -
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
por: Huber CA, et al.
Publicado: (2014)